Content about Novo Nordisk

August 19, 2011

Generic drug maker Sandoz is suing Danish drug maker Novo Nordisk over a generic version of a drug used to treat diabetes, according to published reports.

NEW YORK — Generic drug maker Sandoz is suing Danish drug maker Novo Nordisk over a generic version of a drug used to treat diabetes, according to published reports.

Bloomberg reported that Sandoz, the generics arm of Swiss drug maker Novartis, was suing Novo Nordisk in a Detroit federal court, hoping the court would find that the Sandoz generic version of Novo Nordisk's Prandin (repaglinide) did not infringe on the latter company's patent covering the drug.

August 18, 2011

The Health Mart Healthy Living Tour recently offered free health screenings at the 7th Annual 13th Congressional District Health Fair, hosted by Rep. David Scott, D-Ga., earlier this month.

SAN FRANCISCO — The Health Mart Healthy Living Tour recently offered free health screenings at the 7th Annual 13th Congressional District Health Fair, hosted by Rep. David Scott, D-Ga., earlier this month.

Aboard the Health Mart Healthy Living Tour’s 40-ft. mobile screening unit, tour staff offered screenings that include blood pressure, cholesterol, blood glucose and hemoglobin A1C tests.

July 8, 2011

Novo Nordisk could be outpacing Eli Lilly and Amylin Pharmaceuticals in the diabetes wars, according to an analysis by healthcare market research firm Decision Resources.

BURLINGTON, Mass. — Novo Nordisk could be outpacing Eli Lilly and Amylin Pharmaceuticals in the diabetes wars, according to an analysis by healthcare market research firm Decision Resources.

July 8, 2011

Danish drug maker Novo Nordisk will work with advocacy group Children with Diabetes to distribute materials to children newly diagnosed with Type 1 diabetes, the two said Thursday.

ORLANDO, Fla. — Danish drug maker Novo Nordisk will work with advocacy group Children with Diabetes to distribute materials to children newly diagnosed with Type 1 diabetes, the two said Thursday.

The approximately 7,000 kits, designed to help them learn to live with the condition, include a booklet, savings offers and patient-support videos, and were created based on feedback from CWD members with Type 1 diabetes. Patients can order the kits through their doctors.

June 27, 2011

Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined with other medications, may help patients achieve blood-sugar control.

SAN DIEGO — Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined with other medications, may help patients achieve blood-sugar control.

The drug maker found that combining Victoza (liraglutide [rDNA origin] injection) with metformin and/or sulfonylurea helped patients achieve blood-sugar control.

June 23, 2011

Novo Nordisk has teamed up with actor Chris Noth to underscore the importance of early diabetes screening and detection.

PRINCETON, N.J. — Novo Nordisk has teamed up with actor Chris Noth to underscore the importance of early diabetes screening and detection.

Noth will serve as an ambassador for the national education program Ask.Screen.Know., Novo Nordisk said. As an ambassador, Noth will encourage Americans ages 45 years or older to get tested for diabetes and talk to a healthcare professional about the risk factors through a public service announcement and online at AskScreenKnow.com.

June 15, 2011

Novo Nordisk will serve as the national premier sponsor for the American Diabetes Association's annual fundraising walk in 2011 and 2012, the ADA announced.

ALEXANDRIA, Va. — Novo Nordisk will serve as the national premier sponsor for the American Diabetes Association's annual fundraising walk in 2011 and 2012, the ADA announced.

June 6, 2011

A new survey sponsored by drug maker Novo Nordisk, which polled Type 1 and Type 2 diabetes patients in the United States, United Kingdom, Germany and France, found that about 1-in-5 respondents regularly are unable to attend a full day of work due to disruption caused by episodes of dangerously low blood sugar, also known as hypoglycemic events.

COPENHAGEN, Denmark — A new survey sponsored by drug maker Novo Nordisk, which polled Type 1 and Type 2 diabetes patients in the United States, United Kingdom, Germany and France, found that about 1-in-5 respondents regularly are unable to attend a full day of work due to disruption caused by episodes of dangerously low blood sugar, also known as hypoglycemic events.

April 25, 2011


In the May issue of Consumer Reports, a report found that such independents as McKesson’s Health Mart franchise group are delivering the goods.


McKesson helped capitalize on what has always been an exemplary Health Mart patient experience at the top of last year with a multi-
million-dollar ad campaign that included an ad during the New Orleans Saints/Indianapolis Colts Super Bowl. That 2010 campaign featured real Health Mart pharmacists with stories on how they have impacted their local communities by taking the time to care and provide special services.


April 20, 2011

Kroger is the latest retailer to join the Diabetes Prevention and Control Alliance as a partner.

CINCINNATI — Kroger is the latest retailer to join the Diabetes Prevention and Control Alliance as a partner.

The supermarket conglomerate will implement the DPCA's Diabetes Control Program, which is designed to help patients gain better control of their condition, at select store pharmacies, including stores in the Cincinnati, Columbus and Dayton, Ohio, markets. The retailer also will offer the program in Atlanta, Dallas, Houston and Las Vegas later this year.

April 18, 2011

Albertson's LLC, which operates more than 200 stores across seven states under the Albertsons banner, announced it has joined the Diabetes Prevention and Control Alliance.

BOISE, Idaho — Albertson's LLC, which operates more than 200 stores across seven states under the Albertsons banner, announced it has joined the Diabetes Prevention and Control Alliance.

The retail grocery chain joins such companies as UnitedHealth Group, YMCA, Walgreens and Novo Nordisk as a DPCA partner. Albertson's LLC will participate in the DCPA's Diabetes Control Program, offering its customers community-based programs that help prevent and control diabetes.

April 8, 2011

Danish drug maker Novo Nordisk has received the Corporate Leadership Award from the National Hemophilia Foundation in response to its research and development efforts for the disease, the company said Friday.

PRINCETON, N.J. — Danish drug maker Novo Nordisk has received the Corporate Leadership Award from the National Hemophilia Foundation in response to its research and development efforts for the disease, the company said Friday.

Novo Nordisk president Jurek Gruhn accepted the award at the NHF’s Inaugural Spring Soiree Benefit in New York Thursday. Novo Nordisk makes NovoSeven RT (coagulation factor VIIa [recombinant], room temperature stable), used to treat hemophilia A and B.

March 24, 2011

Novo Nordisk said new data showed that its basal insulin analog is just as effective as human basal insulin in Type 1 diabetes patients ages 2 to 5 years.

COPENHAGEN — Novo Nordisk said new data showed that its basal insulin analog is just as effective as human basal insulin in Type 1 diabetes patients ages 2 to 5 years.

March 17, 2011

A new study conducted by the Institute for Alternative Futures and funded by Novo Nordisk highlighted the top 10 U.S. states that are labeled as "diabetes hot spots" and are projected to carry the brunt of the epidemic over the next 15 years.

WASHINGTON — A new study conducted by the Institute for Alternative Futures and funded by Novo Nordisk highlighted the top 10 U.S. states that are labeled as "diabetes hot spots" and are projected to carry the brunt of the epidemic over the next 15 years.

February 24, 2011

Novo Nordisk has filed for approval of a treatment for a rare genetic bleeding disorder, the Danish drug maker said Wednesday.

PRINCETON, N.J. — Novo Nordisk has filed for approval of a treatment for a rare genetic bleeding disorder, the Danish drug maker said Wednesday.

The company submitted to the Food and Drug Administration its application for recombinant factor XIII compound, for congenital factor XIII deficiency. Current treatments for FXIII deficiency use products derived from human blood plasma, which carries the risk of contamination.

February 2, 2011

A collection of relatively new products helped drive up sales and profits at Novo Nordisk, the Danish drug maker said Wednesday.

BAGSVÆRD, Denmark — A collection of relatively new products helped drive up sales and profits at Novo Nordisk, the Danish drug maker said Wednesday. 

Sales increased by 22% in the North American markets when measured in local currencies, and by 29% when measured in Danish kroner, the company said. Operating profits were $3.5 billion, a 16% increase over 2009.

January 19, 2011

In partnership with Bayer Healthcare Diabetes Care and Novo Nordisk, Giant Eagle is offering its customers free in-store diabetes screenings.

PITTSBURGH — In partnership with Bayer Healthcare Diabetes Care and Novo Nordisk, Giant Eagle is offering its customers free in-store diabetes screenings.

Offerings include A1C tests to measure blood-glucose levels, as well as consultations with Giant Eagle diabetes and pharmaceutical care specialists. The retailer also will have dietitians and wellness coaches on hand at select locations.

Testing is available through Feb. 5, while supplies last.

January 19, 2011

An insulin pen for children made by Novo Nordisk has won a design award, the company said Wednesday.

CRAWLEY, England — An insulin pen for children made by Novo Nordisk has won a design award, the company said Wednesday.

The Danish drug maker won the 2010 Good Design Award from the Chicago Athenaeum Museum of Architecture and Design and the European Centre for Architecture, Art, Design and Urban Studies for its NovoPen Echo, used to treat Type 1 diabetes. The annual award, which the two organizations have given since 1950, are the oldest and among the most coveted for design and innovation, Novo Nordisk said.

January 13, 2011

Danish drug maker Novo Nordisk has created an online resource for diabetes patients that educates them about Novo Nordisk drugs and devices, recipes and nutritional values, and allows them to connect with other patients.

PRINCETON, N.J. — Danish drug maker Novo Nordisk has created an online resource for diabetes patients that educates them about Novo Nordisk drugs and devices, recipes and nutritional values, and allows them to connect with other patients.

December 22, 2010

The Pharmaceutical Research and Manufacturers of America has added four new members to its board.

WASHINGTON — The Pharmaceutical Research and Manufacturers of America has added four new members to its board.

Joining PhRMA are Ian Read, Pfizer's president and CEO; Jerzy Gruhn, Novo Nordisk president; Mark Iwicki, Sunovion Pharmaceuticals president and COO; and Staffan Schuberg, Lundbeck president.

December 21, 2010

A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.

PRINCETON, N.J. — A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.

Emisphere will be paid $57.5 million in potential product development and sales milestone payments by Novo Nordisk — of which $5 million dollars will be payable upon signing — as well as royalties on sales. Further financial details of the agreement were not disclosed.

December 2, 2010

A growing drug-treated population will cause the Type 2 diabetes drug market in China to increase to $2.5 billion by 2014 ...

BURLINGTON, Mass. — A growing drug-treated population will cause the Type 2 diabetes drug market in China to increase to $2.5 billion by 2014, according to a new report by Decision Resources.

The Type 2 diabetes market in China totaled $1.4 billion in 2009, Decision Resources said.

October 21, 2010

A few days after it released a report on how awareness and education play an...

PRINCETON, N.J. A few days after it released a report on how awareness and education play an integral role in the prevention, detection and treatment of diabetes, Novo Nordisk is bringing it to the public.

October 18, 2010

Novo Nordisk is underscoring the importance of diabetes screenings with a new report, the "Novo...

PRINCETON, N.J. Novo Nordisk is underscoring the importance of diabetes screenings with a new report, the Novo Nordisk BlueSheet.

The third edition of the drug maker's BlueSheet report examined various ways awareness and education play an integral role in the prevention, detection and treatment of diabetes. It also provides an update on the Diabetes Advocacy Alliance, a coalition that is committed to helping improve diabetes prevention, detection and care by aligning key diabetes stakeholders around diabetes-related policy and legislative efforts.

October 17, 2010

Pfizer has entered the world of biosimilars through a deal with India-based Biocon to distribute...

NEW YORK Pfizer has entered the world of biosimilars through a deal with India-based Biocon to distribute versions of insulin and insulin analog products around the world, the companies said Monday.